MXPA03002323A - Metodos de diagnostico de cancer colorectal, composiciones y metodos para seleccionar moduladores de cancer colorectal. - Google Patents
Metodos de diagnostico de cancer colorectal, composiciones y metodos para seleccionar moduladores de cancer colorectal.Info
- Publication number
- MXPA03002323A MXPA03002323A MXPA03002323A MXPA03002323A MXPA03002323A MX PA03002323 A MXPA03002323 A MX PA03002323A MX PA03002323 A MXPA03002323 A MX PA03002323A MX PA03002323 A MXPA03002323 A MX PA03002323A MX PA03002323 A MXPA03002323 A MX PA03002323A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- colorectal cancer
- diagnosis
- screening
- compositions
- Prior art date
Links
Classifications
-
- G01N33/57515—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G01N33/57535—
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Pathology (AREA)
- Rheumatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66373300A | 2000-09-15 | 2000-09-15 | |
| US09/930,020 US20030077568A1 (en) | 2000-09-15 | 2001-08-14 | Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators |
| PCT/US2001/028716 WO2002021996A2 (en) | 2000-09-15 | 2001-09-14 | Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03002323A true MXPA03002323A (es) | 2003-08-01 |
Family
ID=27098811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03002323A MXPA03002323A (es) | 2000-09-15 | 2001-09-14 | Metodos de diagnostico de cancer colorectal, composiciones y metodos para seleccionar moduladores de cancer colorectal. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20030077568A1 (es) |
| EP (1) | EP1317669A4 (es) |
| JP (1) | JP2004515225A (es) |
| AU (1) | AU2001290902A1 (es) |
| CA (1) | CA2422278A1 (es) |
| MX (1) | MXPA03002323A (es) |
| WO (1) | WO2002021996A2 (es) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030064946A1 (en) * | 2000-08-09 | 2003-04-03 | Mcswiggen James | Method and reagent for the inhibition of calcium activated chloride channel-1 (CLCA-1) |
| US20050233353A1 (en) * | 2001-02-27 | 2005-10-20 | Markowitz Sanford D | Methods and compositions for categorizing patients |
| US7118912B2 (en) | 2002-08-26 | 2006-10-10 | Case Western Reserve University | Methods and compositions for categorizing patients |
| US7081516B2 (en) | 2002-08-26 | 2006-07-25 | Case Western Reserve University | Methods for categorizing patients |
| US20060035237A1 (en) | 2002-08-26 | 2006-02-16 | Markowitz Sanford D | Methods and compositions for categorizing patients |
| GB0208089D0 (en) | 2002-04-09 | 2002-05-22 | Oxford Glycosciences Uk Ltd | Protein |
| US20040014047A1 (en) * | 2002-07-18 | 2004-01-22 | Isis Pharmaceuticals Inc. | Antisense modulation of LIM domain kinase 1 expression |
| EP1546731A2 (en) * | 2002-09-30 | 2005-06-29 | Oncotherapy Science, Inc. | Method for treating or preventing metastasis of colorectal cancers |
| US7105657B2 (en) * | 2002-11-08 | 2006-09-12 | Board Of Regents Of The University Of Nebraska | Compositions and methods for inhibiting pancreatic cancer metastasis |
| US20060241035A1 (en) | 2003-07-11 | 2006-10-26 | Daria Onichtchouk | Use of dg153 secreted protein products for preventing and treating pancreatic disease and/or obesity and/or metabolic syndrome |
| WO2005080597A1 (en) * | 2004-02-24 | 2005-09-01 | Oncotherapy Science, Inc. | Method for diagnosing colorectal cancers |
| EP1856286A2 (en) * | 2005-02-11 | 2007-11-21 | Wisconsin Alumni Research Foundation | Mir-155 assay |
| JP4759612B2 (ja) * | 2005-04-13 | 2011-08-31 | コンセホ スペリオール デ インベスティガシオネス シエンティフィカス | 癌治療化合物のin vitroにおける同定方法 |
| EP2166357A1 (en) * | 2005-08-18 | 2010-03-24 | Zadec Aps | Protein marker for diagnosing colorectal cancer |
| NZ544432A (en) * | 2005-12-23 | 2009-07-31 | Pacific Edge Biotechnology Ltd | Prognosis prediction for colorectal cancer using a prognositc signature comprising markers ME2 and FAS |
| NZ593228A (en) * | 2006-01-11 | 2012-10-26 | Genomic Health Inc | Gene expression markers (inhba) for colorectal cancer prognosis |
| AU2008296927C1 (en) * | 2007-09-06 | 2015-08-13 | Case Western Reserve University | Methods for diagnosing and treating cancers |
| RU2565540C2 (ru) * | 2007-10-23 | 2015-10-20 | Клиникал Джиномикс Пти. Лтд. | Способ диагностики неоплазм-ii |
| JP2012525159A (ja) * | 2009-05-01 | 2012-10-22 | ジェノミック ヘルス, インコーポレイテッド | 結腸直腸癌の再発および化学療法に対する応答の可能性における遺伝子発現プロファイルアルゴリズムおよび試験 |
| CN115267189A (zh) * | 2022-07-28 | 2022-11-01 | 温州医科大学附属第二医院(温州医科大学附属育英儿童医院) | Gh作为结直肠癌血清生物标志物的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5356817A (en) * | 1988-06-09 | 1994-10-18 | Yale University | Methods for detecting the onset, progression and regression of gynecologic cancers |
| CA2369319A1 (en) * | 1999-03-15 | 2000-09-21 | Eos Biotechnology, Inc. | Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators |
-
2001
- 2001-08-14 US US09/930,020 patent/US20030077568A1/en not_active Abandoned
- 2001-09-14 CA CA002422278A patent/CA2422278A1/en not_active Abandoned
- 2001-09-14 MX MXPA03002323A patent/MXPA03002323A/es unknown
- 2001-09-14 AU AU2001290902A patent/AU2001290902A1/en not_active Abandoned
- 2001-09-14 WO PCT/US2001/028716 patent/WO2002021996A2/en not_active Ceased
- 2001-09-14 EP EP01970958A patent/EP1317669A4/en not_active Withdrawn
- 2001-09-14 JP JP2002526255A patent/JP2004515225A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| US20030077568A1 (en) | 2003-04-24 |
| EP1317669A4 (en) | 2005-04-06 |
| CA2422278A1 (en) | 2002-03-21 |
| EP1317669A2 (en) | 2003-06-11 |
| AU2001290902A1 (en) | 2002-03-26 |
| WO2002021996A2 (en) | 2002-03-21 |
| WO2002021996A3 (en) | 2003-02-06 |
| JP2004515225A (ja) | 2004-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2002068677A8 (en) | Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer | |
| AU2002215345A1 (en) | Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer | |
| MXPA03002323A (es) | Metodos de diagnostico de cancer colorectal, composiciones y metodos para seleccionar moduladores de cancer colorectal. | |
| AU2002245317A1 (en) | Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer | |
| AU2002347428A1 (en) | Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer | |
| AU2002309583A1 (en) | Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer | |
| AU2001231199A1 (en) | Compositions and methods for the early diagnosis of ovarian cancer | |
| AU2002257004A1 (en) | Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators | |
| AU3983201A (en) | Compositions and methods for the early diagnosis of ovarian cancer | |
| AU3491001A (en) | Compositions and methods for the early diagnosis of ovarian cancer | |
| EP1434881A4 (en) | METHOD FOR DIAGNOSIS OF CANCER COMPOSITIONS AND METHOD FOR SCREENING ON CANCER MODULATORS | |
| WO2004063355A3 (en) | Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of matastatic cancer | |
| AU2002249871A1 (en) | Novel methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators | |
| AU2001265296A1 (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer | |
| AU2002339865A8 (en) | Methods and compositions useful for diagnosis, staging, and treatment of cancers and tumors | |
| AU2003300368A1 (en) | Methods and compositions for the diagnosis, prognosis, and treatment of cancer | |
| MXPA03007827A (es) | Metodo y composicion para la coloracion permanente gradual de cabello. | |
| AU3755300A (en) | Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators | |
| AU2001251013A1 (en) | Compositions and methods of diagnosing, monitoring, staging, imaging and treating colon cancer | |
| WO2004058153A9 (en) | Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 21617, 39228, 49928, 54476. | |
| AU3752700A (en) | Novel methods of diagnosing and treating breast cancer, compositions, and methods of screening for breast cancer modulators | |
| AU4224599A (en) | Anti-prostate cancer vaccines, and methods of making, using and evaluating the same | |
| AU2001251223A1 (en) | Compositions and methods for diagnosing, monitoring, staging, imaging and treating stomach cancer | |
| AU2002311859A1 (en) | Compositions and methods for treating colorectal polyps and cancer | |
| AU2002239431A1 (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer |